Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Venus Medtech (Hangzhou) Inc.
  6. Summary
    2500   CNE100003PJ8

VENUS MEDTECH (HANGZHOU) INC.

(2500)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
09/20/2021 09/21/2021 09/23/2021 09/24/2021 09/27/2021 Date
39.8 39.5 38.7 40.8 40.15 Last
5418270 1195000 4443500 1951000 1782503 Volume
-5.58% -0.75% -2.03% +5.43% -1.59% Change
Estimated financial data (e)
Sales 2021 554 M 85,9 M 85,9 M
Net income 2021 -152 M -23,5 M -23,5 M
Net cash position 2021 2 429 M 376 M 376 M
P/E ratio 2021 -96,8x
Yield 2021 -
Sales 2022 1 004 M 156 M 156 M
Net income 2022 103 M 15,9 M 15,9 M
Net cash position 2022 2 236 M 346 M 346 M
P/E ratio 2022 144x
Yield 2022 -
Capitalization 14 687 M 2 275 M 2 276 M
EV / Sales 2021 22,1x
EV / Sales 2022 12,4x
Nbr of Employees 675
Free-Float 76,4%
More Financials
Company
Venus MedTech (HangZhou) Inc. is a China-based company engaged in the research, development, manufacture and sales of minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8 / TAV8 and... 
More about the company
Ratings of Venus Medtech (Hangzhou) Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about VENUS MEDTECH (HANGZHOU) INC.
08/31Venus Medtech Hangzhou Inc. Reports Earnings Results for the Half Year Ended June 30, 2..
CI
08/31Venus Medtech Inc. Announces Unaudited Consolidated Earnings Results for the Six Months..
CI
08/16VENUS MEDTECH HANGZHOU : Unveils Plan to Buy Medical Device Research and Development Busin..
MT
07/27VENUS MEDTECH HANGZHOU : Appoints Professor Martin B. Leon as Global Principal Investigato..
PR
07/27VENUS MEDTECH HANGZHOU : Appoints Professor Martin B. Leon as Global Principal Investigato..
AQ
07/27Venus Medtech Inc. Appoints Martin B. Leon as the Global Principal Investigator of RDN ..
CI
07/26VENUS MEDTECH HANGZHOU : Voluntary announcement unaudited operating statistics for the per..
PU
07/26Venus Medtech Inc. Announces Unaudited Group Revenue Results for the Six Months Ended J..
CI
06/30Venus Medtech Inc. Announces Formation of Joint Venture Company with Healium Medical Lt..
CI
05/06VENUS MEDTECH HANGZHOU : Voluntary announcement latest investment project
PU
05/05VENUS MEDTECH HANGZHOU : Invests in Medical Device Manufacturer
MT
05/05Hangzhou Valgen Medtech Technology Co., Ltd. announced that it has received $200 millio..
CI
04/20VENUS MEDTECH HANGZHOU : Proxy form for use at the 2021 first class meeting of holders of ..
PU
04/20VENUS MEDTECH HANGZHOU : Proxy form for use at the 2021 first class meeting of holders of ..
PU
04/20VENUS MEDTECH HANGZHOU : Notice of 2021 first class meeting of holders of unlisted foreign..
PU
More news
News in other languages on VENUS MEDTECH (HANGZHOU) INC.

- No features available -

More news
Chart VENUS MEDTECH (HANGZHOU) INC.
Duration : Period :
Venus Medtech (Hangzhou) Inc. Technical Analysis Chart | 2500 | CNE100003PJ8 | MarketScreener
Technical analysis trends VENUS MEDTECH (HANGZHOU) INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 33,30 CNY
Average target price 60,45 CNY
Spread / Average Target 81,5%
EPS Revisions
Managers and Directors
Zhen Jun Zi Executive Director & General Manager
Haiyue Ma Chief Financial Officer & Joint Secretary
Min Zeng Chairman
Yan Xiao Chairman-Supervisory Board
Hou-Sen Lim Chief Operating Officer, Executive Director & CTO
Sector and Competitors